<SEC-DOCUMENT>0001213900-20-007127-index.html : 20200323
<SEC-HEADER>0001213900-20-007127.hdr.sgml : 20200323
<ACCEPTANCE-DATETIME>20200323163027
ACCESSION NUMBER:		0001213900-20-007127
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200318
ITEM INFORMATION:		Changes in Registrant's Certifying Accountant
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200323
DATE AS OF CHANGE:		20200323

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ArTara Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001359931
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36694
		FILM NUMBER:		20735217

	BUSINESS ADDRESS:	
		STREET 1:		1 LITTLE WEST 12TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10014
		BUSINESS PHONE:		646-844-0337

	MAIL ADDRESS:	
		STREET 1:		1 LITTLE WEST 12TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10014

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROTEON THERAPEUTICS INC
		DATE OF NAME CHANGE:	20060420
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea119830-8k_artarathera.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea119830-8k_artarathera.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16.1
<SEQUENCE>2
<FILENAME>ea119830ex16-1_artarathera.htm
<DESCRIPTION>LETTER DATED MARCH 19, 2020 FROM ?ERNST AND YOUNG LLP TO THE SECURITIES AND EXCHANGE COMMISSION.
<TEXT>
Document 2 - file: ea119830ex16-1_artarathera.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: logo.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: logo2.jpg

</DOCUMENT>
</SEC-DOCUMENT>